Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 27;109(10):3336–3349. doi: 10.1111/cas.13778

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

The results showed the patients with high expression of COL4A4, ERMP1 and PRELID2 had a better overall survival (OS) (P < .05). In contrast, patients with low expression of NOG, SPI1, TGFβ1, TYRP1 and VIM had better overall survival (P < .05). ( ) High expression.

Inline graphic — The results showed the patients with high expression of COL4A4, ERMP1 and PRELID2 had a better overall survival (OS) (P < .05). In contrast, patients with low expression of NOG, SPI1, TGFβ1, TYRP1 and VIM had better overall survival (P < .05). ( ) High expression.